TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotrans i Nord AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
11,977
|
10,560
|
14,159 |
| Financial expenses |
406
|
295
|
145 |
| Earnings before taxes |
-1,026
|
-2,058
|
-509 |
| EBITDA |
1,410
|
-129
|
1,054 |
| Total assets |
15,377
|
18,574
|
12,684 |
| Current assets |
3,153
|
4,573
|
2,127 |
| Current liabilities |
3,656
|
5,152
|
4,376 |
| Equity capital |
645
|
658
|
697 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
8
|
8
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
4.2%
|
3.5%
|
5.5% |
| Turnover per employee |
1,497
|
1,320
|
1,770 |
| Profit as a percentage of turnover |
-8.6%
|
-19.5%
|
-3.6% |
| Return on assets (ROA) |
-4.0%
|
-9.5%
|
-2.9% |
| Current ratio |
86.2%
|
88.8%
|
48.6% |
| Return on equity (ROE) |
-159.1%
|
-312.8%
|
-73.0% |
| Change turnover |
1,227
|
-4,604
|
-336 |
| Change turnover % |
11%
|
-30%
|
-2% |
| Chg. No. of employees |
0
|
0
|
-2 |
| Chg. No. of employees % |
0%
|
0%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.